We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$17.8M
Cap. Flow
-$9.9M
Cap. Flow %
-7.46%
Top 10 Hldgs %
46.17%
Holding
130
New
18
Increased
25
Reduced
65
Closed
22

Top Buys

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$3.84M
2
SAGE
Sage Therapeutics
SAGE
+$2.55M
3
NAII icon
Natural Alternatives International
NAII
+$1.88M
4
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.85M
5
LHCG
LHC Group LLC
LHCG
+$1.62M

Top Sells

Rank Stock Value
1
KTEC
Key Technology Inc
KTEC
+$11.2M
2
AERI
Aerie Pharmaceuticals
AERI
+$4.12M
3
PFPT
Proofpoint, Inc.
PFPT
+$3.65M
4
ABCB icon
Ameris Bancorp
ABCB
+$3.13M
5
ISBC
Investors Bancorp, Inc.
ISBC
+$2.81M

Sector Composition

Rank Sector Weight
1 Industrials 15.96%
2 Healthcare 13.66%
3 Technology 11.8%
4 Consumer Staples 6.96%
5 Financials 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APOG icon
101
Apogee Enterprises
APOG
$833M
$249K 0.19%
5,747
-3,851
-40% -$172K
STAG icon
102
STAG Industrial
STAG
$7.44B
$249K 0.19%
10,406
-7,412
-42% -$181K
BLUE
103
DELISTED
bluebird bio
BLUE
$242K 0.18%
109
-79
-42% -$201K
SLAB icon
104
Silicon Laboratories
SLAB
$7.14B
$242K 0.18%
2,699
-3,703
-58% -$349K
ACIW icon
105
ACI Worldwide
ACIW
$6.12B
$241K 0.18%
10,180
-25,054
-71% -$592K
CLVS
106
DELISTED
Clovis Oncology, Inc.
CLVS
$224K 0.17%
4,228
-13,233
-76% -$772K
SRPT icon
107
Sarepta Therapeutics
SRPT
$1.64B
$209K 0.16%
2,826
-7,445
-72% -$496K
ANAB icon
108
AnaptysBio
ANAB
$1.54B
$205K 0.15%
+1,976
New +$223K
ABM icon
109
ABM Industries
ABM
$2.89B
– –
-29,231
Closed -$1.1M
ACAD icon
110
Acadia Pharmaceuticals
ACAD
$4.51B
– –
-77,113
Closed -$2.32M
BGS icon
111
B&G Foods
BGS
$303M
– –
-69,514
Closed -$2.45M
CAKE icon
112
Cheesecake Factory
CAKE
$5.03B
– –
-16,228
Closed -$780K
CPS icon
113
Cooper-Standard Automotive
CPS
$517M
– –
-6,476
Closed -$795K
CRUS icon
114
Cirrus Logic
CRUS
$6.76B
– –
-8,121
Closed -$420K
CHRN
115
ChronoScale Holdings
CHRN
$2.69B
– –
-402
Closed -$193K
KYNB
116
Kyntra Bio
KYNB
$27.4M
– –
-278
Closed -$328K
PBYI icon
117
Puma Biotechnology
PBYI
$398M
– –
-3,727
Closed -$368K
RARE icon
118
Ultragenyx Pharmaceutical
RARE
$2.46B
– –
-6,276
Closed -$292K
SAM icon
119
Boston Beer
SAM
$1.95B
– –
-3,184
Closed -$609K
TXT icon
120
Textron
TXT
$14.9B
– –
-9,599
Closed -$543K
WMS icon
121
Advanced Drainage Systems
WMS
$10.6B
– –
-34,506
Closed -$821K
VIVS
122
VivoSim Labs
VIVS
$1.21M
– –
-136
Closed -$44K
ABB
123
DELISTED
ABB Ltd
ABB
– –
-10,000
Closed -$268K
NTUS
124
DELISTED
Natus Medical Inc
NTUS
– –
-12,959
Closed -$496K
FLXN
125
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-45,334
Closed -$1.14M
2 3 4
5
6

Similar funds

CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
QI
Quilter Investors London, United Kingdom $22.3M AUM 6.63% 1-Year Est. Return
HWM
Highwater Wealth Management Glendale, Colorado $22.6M AUM 3.46% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
MAU
MRA Associates USA Phoenix, Arizona $25.4M AUM 0.38% 1-Year Est. Return
FCG
FrontFour Capital Group Greenwich, Connecticut $26.5M AUM 17.69% 1-Year Est. Return

Pacific View Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Pacific View Asset Management held 130 positions worth $133M, down 12% from $151M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Pacific View Asset Management withdrew a net $9.9M in Q1 2018, closing 22 positions and reducing 65 holdings. Its most notable exit was Key Technology Inc, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Pacific View Asset Management opened a new position in Aimmune Therapeutics worth $3.47M.

  • Pacific View Asset Management's largest Q1 2018 buy was Aimmune Therapeutics: 108,984 shares worth $3.47M.
  • Pacific View Asset Management added most to Sage Therapeutics in Q1 2018, an estimated $2.55M increase.
  • Pacific View Asset Management's biggest Q1 2018 reduction was Aerie Pharmaceuticals, cutting an estimated $4.12M.
  • Pacific View Asset Management fully exited Key Technology Inc in Q1 2018, selling an estimated $11.2M.
  • Pacific View Asset Management's ten largest holdings make up 46% of its $133M portfolio in Q1 2018.
  • Pacific View Asset Management opened 18 new positions and closed 22 in Q1 2018.
  • Pacific View Asset Management's portfolio value fell 12% quarter-over-quarter to $133M.

Based on Pacific View Asset Management's 13F filing for Q1 2018, filed 15 May 2018.